269 related articles for article (PubMed ID: 11532246)
1. Distribution of TGF-beta, the TGF-beta type I receptor and the R-II receptor in peripheral nerves and mechanoreceptors; observations on changes after traumatic injury.
Stark B; Carlstedt T; Risling M
Brain Res; 2001 Sep; 913(1):47-56. PubMed ID: 11532246
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
3. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
4. Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo.
Quan T; He T; Kang S; Voorhees JJ; Fisher GJ
J Invest Dermatol; 2002 Aug; 119(2):499-506. PubMed ID: 12190876
[TBL] [Abstract][Full Text] [Related]
5. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
6. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
7. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.
Kjellman C; Olofsson SP; Hansson O; Von Schantz T; Lindvall M; Nilsson I; Salford LG; Sjögren HO; Widegren B
Int J Cancer; 2000 May; 89(3):251-8. PubMed ID: 10861501
[TBL] [Abstract][Full Text] [Related]
8. Pericellular Griffonia simplicifolia I isolectin B4-binding ring structures in the dorsal root ganglia following peripheral nerve injury in rats.
Li L; Zhou XF
J Comp Neurol; 2001 Oct; 439(3):259-74. PubMed ID: 11596053
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factors beta1, beta2 and beta3 and their receptors are differentially expressed in human peritoneal fibroblasts in response to hypoxia.
Saed GM; Collins KL; Diamond MP
Am J Reprod Immunol; 2002 Dec; 48(6):387-93. PubMed ID: 12607775
[TBL] [Abstract][Full Text] [Related]
10. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts.
Chin GS; Liu W; Peled Z; Lee TY; Steinbrech DS; Hsu M; Longaker MT
Plast Reconstr Surg; 2001 Aug; 108(2):423-9. PubMed ID: 11496185
[TBL] [Abstract][Full Text] [Related]
12. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.
De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P
J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100
[TBL] [Abstract][Full Text] [Related]
13. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor.
Rotzer D; Roth M; Lutz M; Lindemann D; Sebald W; Knaus P
EMBO J; 2001 Feb; 20(3):480-90. PubMed ID: 11157754
[TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β (TGF-β) signaling in healthy human fetal skin: a descriptive study.
Walraven M; Beelen RH; Ulrich MM
J Dermatol Sci; 2015 May; 78(2):117-24. PubMed ID: 25795202
[TBL] [Abstract][Full Text] [Related]
16. Regulation mechanisms of retinal pigment epithelial cell migration by the TGF-beta superfamily.
Mitsuhiro MR; Eguchi S; Yamashita H
Acta Ophthalmol Scand; 2003 Dec; 81(6):630-8. PubMed ID: 14641267
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
18. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
19. Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds.
Cowin AJ; Holmes TM; Brosnan P; Ferguson MW
Eur J Dermatol; 2001; 11(5):424-31. PubMed ID: 11525949
[TBL] [Abstract][Full Text] [Related]
20. Reversal of liver fibrosis in aryl hydrocarbon receptor null mice by dietary vitamin A depletion.
Andreola F; Calvisi DF; Elizondo G; Jakowlew SB; Mariano J; Gonzalez FJ; De Luca LM
Hepatology; 2004 Jan; 39(1):157-66. PubMed ID: 14752834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
